Home › Overweight › Alabama

Pag-aaral pangklinika para sa Overweight sa Alabama

32 pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa mga site sa Alabama.

Mga Lungsod sa Alabama

Opisyal na teksto ng pag-aaral (English)

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

AMR Clinical - Mobile, Mobile

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07685808

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Cahaba Research - Pelham /ID# 282381, Pelham

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07752979

A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

Cullman Clinical Trials, Cullman

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07823608

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

University of Alabama - Birmingham, Birmingham

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07837973

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Pinnacle Research Group, LLC, Anniston
Central Research Associates, Birmingham
Cahaba Research - Pelham, Pelham

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07794579

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Pinnacle Research Group LLC, Anniston
Univ of Alabama Birmingham, Birmingham
Chambliss Clinical Trials LLC, Montgomery

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07720271

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Digestive Health Specialists, Dothan

Nagre-recruitPhase 3

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Digestive Health Specialists, Dothan

Nagre-recruitPhase 3

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Birmingham Clinical Research, Birmingham

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Cullman Clinical Trials, Cullman

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07369011

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Fairhope
Research Site, Huntsville
Research Site, Mobile

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07784270

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

AMR Clinical, Mobile

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

MFA Clinical Research, Tuscaloosa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07321886

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Alliance For Multispecialty Research - Daphne, Daphne
Eastern Shore Research Institute, Fairhope
Heart Center Research LLC, Huntsville
at 2 pa

Nagre-recruitPhase 3

Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Birmingham Clinical Research, Birmingham
Cullman Clinical Trials, Cullman

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07282600

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Birmingham
AURORA-1 Clinical Site, Huntsville

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Birmingham
AURORA-2 Clinical Site, Huntsville

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Lakeview Clinical Research, Guntersville

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Pinnacle Research Group, Anniston
Alabama Clinical Therapeutics, Birmingham
University of Alabama at Birmingham, Birmingham

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Birmingham

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Uni of Alabama at Birmingham, Birmingham

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07770841

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Univ of Alabama Birmingham, Birmingham

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07533175

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Anniston
Kailera Clinical Site, Birmingham
Kailera Clinical Site, Cullman

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284875

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Cullman

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Pinnacle Research Group LLC, Anniston
Alliance For Multispecialty Research - Daphne, Daphne
Alliance for Multispecialty Research Mobile, Mobile

Nagre-recruitPhase 3

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684235

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Cahaba Research, Inc., Pelham

Nagre-recruitPhase 3

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Dothan
Research Site, Huntsville

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Birmingham
ACCOMPLISH-1 Research Site, Birmingham

Nagre-recruitPhase 3

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07654361

Time-restricted Eating for Postpartum Weight Loss

University of Alabama at Birmingham, Birmingham

Nagre-recruit

Edad 18 pataas · Kababaihan · Na-update Hun 29, 2026 · NCT06491537

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

University of Alabama at Birmingham, Birmingham

Nagre-recruit

Edad 18 hanggang 45 · Kababaihan · Na-update Hun 24, 2026 · NCT05124808

FELLAShip to Better Health

The Worship Center Cristian Church, Birmingham

Nagre-recruit

Edad 18 pataas · Kalalakihan · Na-update Ene 22, 2026 · NCT07220213

International Weight Control Registry

University of Alabama at Birmingham, Birmingham

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 19, 2024 · NCT04907396

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.